VICTORIA, BC — /CNW/ — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that… Read More
First Numinus Network™ partner enters into agreement Recent cost containment initiatives have resulted in approximately $4.2 million of annualized savings, extending cash runway Well positioned to provide psychedelic-assisted therapy insurance reimbursement, as a result… Read More
The new cancer centre in Kamloops will bring cancer care closer to home for patients and families in the Interior. People in Kamloops and throughout the Thompson-Cariboo region are one… Read More
VANCOUVER, BC — Clinical Trials BC is pleased to announce the recipients of their annual awards: the Leadership & Advocacy Award and the Service & Support Award. Watch the awards… Read More
TORONTO, ON — Canadian Institutes of Health Research Last year, as the disease spread around the globe, Canada experienced its first major mpox outbreak. Increasingly, zoonotic diseases that were once… Read More
